0 XP   0   0   0

Vivesto AB
Buy, Hold or Sell?

I guess you are interested in Vivesto AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Vivesto

Let's start. I'm going to help you getting a better view of Vivesto AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Vivesto AB even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Vivesto AB is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Vivesto AB. The closing price on 2022-09-30 was kr0.7215 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Vivesto AB Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Vivesto AB.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Vivesto earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Vivesto to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of -72.4% means that kr-0.72 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vivesto AB:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-72.4%+72.4%
TTM-72.4%YOY-1,254.9%+1,182.6%
TTM-72.4%5Y-308.9%+236.5%
5Y-308.9%10Y-308.9%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.7%-0.7%
TTM-72.4%1.0%-73.4%
YOY-1,254.9%1.7%-1,256.6%
5Y-308.9%0.6%-309.5%
10Y-308.9%1.2%-310.1%
1.1.2. Return on Assets

Shows how efficient Vivesto is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vivesto to the Drug Manufacturers-Specialty & Generic industry mean.
  • -3.7% Return on Assets means that Vivesto generated kr-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vivesto AB:

  • The MRQ is -5.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.9%TTM-3.7%-2.3%
TTM-3.7%YOY-7.6%+3.9%
TTM-3.7%5Y-4.4%+0.8%
5Y-4.4%10Y-4.4%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.9%0.2%-6.1%
TTM-3.7%0.2%-3.9%
YOY-7.6%0.1%-7.7%
5Y-4.4%-0.1%-4.3%
10Y-4.4%0.2%-4.6%
1.1.3. Return on Equity

Shows how efficient Vivesto is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vivesto to the Drug Manufacturers-Specialty & Generic industry mean.
  • -6.2% Return on Equity means the company generated kr-0.06 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vivesto AB:

  • The MRQ is -6.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -4.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.2%TTM-4.1%-2.1%
TTM-4.1%YOY-9.9%+5.8%
TTM-4.1%5Y-5.3%+1.2%
5Y-5.3%10Y-5.3%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.2%0.8%-7.0%
TTM-4.1%0.6%-4.7%
YOY-9.9%0.6%-10.5%
5Y-5.3%0.1%-5.4%
10Y-5.3%0.5%-5.8%

1.2. Operating Efficiency of Vivesto AB.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Vivesto is operating .

  • Measures how much profit Vivesto makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vivesto to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vivesto AB:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-67.0%+67.0%
TTM-67.0%YOY-1,215.1%+1,148.1%
TTM-67.0%5Y-296.6%+229.6%
5Y-296.6%10Y-296.6%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.5%-3.5%
TTM-67.0%2.3%-69.3%
YOY-1,215.1%3.9%-1,219.0%
5Y-296.6%3.5%-300.1%
10Y-296.6%1.9%-298.5%
1.2.2. Operating Ratio

Measures how efficient Vivesto is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 0.0% means that the operating costs are kr0.00for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Vivesto AB:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.340-1.340
TTM1.340YOY13.233-11.894
TTM1.3405Y3.718-2.379
5Y3.71810Y3.7180.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.480-1.480
TTM1.3401.435-0.095
YOY13.2331.383+11.850
5Y3.7181.363+2.355
10Y3.7181.160+2.558

1.3. Liquidity of Vivesto AB.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Vivesto is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 680.5% means the company has kr6.80 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Vivesto AB:

  • The MRQ is 6.805. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.579. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.805TTM4.579+2.226
TTM4.579YOY1.684+2.895
TTM4.5795Y4.000+0.579
5Y4.00010Y4.0000.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ6.8051.887+4.918
TTM4.5791.900+2.679
YOY1.6842.104-0.420
5Y4.0002.156+1.844
10Y4.0001.840+2.160
1.3.2. Quick Ratio

Measures if Vivesto is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean)
  • A Quick Ratio of 1,230.7% means the company can pay off kr12.31 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vivesto AB:

  • The MRQ is 12.307. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.708. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ12.307TTM5.708+6.599
TTM5.708YOY2.031+3.677
TTM5.7085Y4.972+0.735
5Y4.97210Y4.9720.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ12.3070.641+11.666
TTM5.7080.784+4.924
YOY2.0310.809+1.222
5Y4.9720.838+4.134
10Y4.9720.834+4.138

1.4. Solvency of Vivesto AB.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Vivesto assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Asset Ratio of 0.05 means that Vivesto assets are financed with 5.3% credit (debt) and the remaining percentage (100% - 5.3%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Vivesto AB:

  • The MRQ is 0.053. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.098. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.053TTM0.098-0.046
TTM0.098YOY0.235-0.136
TTM0.0985Y0.126-0.027
5Y0.12610Y0.1260.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0530.429-0.376
TTM0.0980.412-0.314
YOY0.2350.391-0.156
5Y0.1260.390-0.264
10Y0.1260.396-0.270
1.4.2. Debt to Equity Ratio

Measures if Vivesto is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Equity ratio of 5.6% means that company has kr0.06 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vivesto AB:

  • The MRQ is 0.056. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.115. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.056TTM0.115-0.059
TTM0.115YOY0.307-0.192
TTM0.1155Y0.153-0.038
5Y0.15310Y0.1530.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0560.688-0.632
TTM0.1150.677-0.562
YOY0.3070.624-0.317
5Y0.1530.678-0.525
10Y0.1530.689-0.536

2. Market Valuation of Vivesto AB

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Vivesto.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -2.33 means the investor is paying kr-2.33 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vivesto AB:

  • The EOD is -2.629. Company is losing money. -2
  • The MRQ is -2.332. Company is losing money. -2
  • The TTM is -1.921. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-2.629MRQ-2.332-0.297
MRQ-2.332TTM-1.921-0.412
TTM-1.921YOY--1.921
TTM-1.9215Y-1.536-0.384
5Y-1.53610Y-1.5360.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-2.6290.297-2.926
MRQ-2.3320.416-2.748
TTM-1.9211.360-3.281
YOY-3.493-3.493
5Y-1.5366.176-7.712
10Y-1.5366.668-8.204

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Vivesto is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 0.54 means the investor is paying kr0.54 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Vivesto AB:

  • The EOD is 0.605. Very good. +2
  • The MRQ is 0.537. Very good. +2
  • The TTM is 0.959. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.605MRQ0.537+0.068
MRQ0.537TTM0.959-0.423
TTM0.959YOY2.452-1.493
TTM0.9595Y1.258-0.299
5Y1.25810Y1.2580.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD0.6051.424-0.819
MRQ0.5371.617-1.080
TTM0.9592.042-1.083
YOY2.4522.274+0.178
5Y1.2582.006-0.748
10Y1.2581.538-0.280

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Vivesto AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--1.1934.331-72%1.1930%3.703-68%3.703-68%
Book Value Per Share Growth---0.2000.000-100%1.193-117%0.239-184%0.239-184%
Current Ratio--6.8054.579+49%1.684+304%4.000+70%4.000+70%
Debt To Asset Ratio--0.0530.098-47%0.235-78%0.126-58%0.126-58%
Debt To Equity Ratio--0.0560.115-52%0.307-82%0.153-64%0.153-64%
Dividend Per Share----0%-0%-0%-0%
Eps---0.074-0.069-8%-0.120+61%-0.079+6%-0.079+6%
Gains Per Share---0.2000.000-100%1.193-117%0.239-184%0.239-184%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----0.7240%-12.5490%-3.0890%-3.0890%
Operating Margin----0.6700%-12.1510%-2.9660%-2.9660%
Operating Ratio---1.340-100%13.233-100%3.718-100%3.718-100%
Pb Ratio0.605+11%0.5370.959-44%2.452-78%1.258-57%1.258-57%
Pe Ratio-2.629-13%-2.332-1.921-18%--100%-1.536-34%-1.536-34%
Price Per Share0.722+11%0.6401.821-65%2.925-78%2.042-69%2.042-69%
Quick Ratio--12.3075.708+116%2.031+506%4.972+148%4.972+148%
Return On Assets---0.059-0.037-38%-0.076+28%-0.044-25%-0.044-25%
Return On Equity---0.062-0.041-34%-0.099+59%-0.053-16%-0.053-16%
 EOD+1 -2MRQTTM+8 -6YOY+11 -35Y+9 -510Y+9 -5

3.2. Fundamental Score

Let's check the fundamental score of Vivesto AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.629
Price to Book Ratio (EOD)Between0-10.605
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than112.307
Current Ratio (MRQ)Greater than16.805
Debt to Asset Ratio (MRQ)Less than10.053
Debt to Equity Ratio (MRQ)Less than10.056
Return on Equity (MRQ)Greater than0.15-0.062
Return on Assets (MRQ)Greater than0.05-0.059
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Vivesto AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.416
Ma 20Greater thanMa 500.762
Ma 50Greater thanMa 1000.845
Ma 100Greater thanMa 2000.830
OpenGreater thanClose0.711
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. All numbers in thousands.

Summary
Total Assets651,496
Total Liabilities34,309
Total Stockholder Equity617,187
 As reported
Total Liabilities 34,309
Total Stockholder Equity+ 617,187
Total Assets = 651,496

Assets

Total Assets651,496
Total Current Assets207,859
Long-term Assets207,859
Total Current Assets
Cash And Cash Equivalents 1,711
Short-term Investments 187,117
Inventory 8,914
Other Current Assets 10,117
Total Current Assets  (as reported)207,859
Total Current Assets  (calculated)207,859
+/-0
Long-term Assets
Property Plant Equipment 14,296
Intangible Assets 429,040
Long-term Assets  (as reported)443,637
Long-term Assets  (calculated)443,336
+/- 301

Liabilities & Shareholders' Equity

Total Current Liabilities30,547
Long-term Liabilities3,762
Total Stockholder Equity617,187
Total Current Liabilities
Short-term Debt 3,054
Accounts payable 8,065
Other Current Liabilities 19,428
Total Current Liabilities  (as reported)30,547
Total Current Liabilities  (calculated)30,547
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)3,762
Long-term Liabilities  (calculated)0
+/- 3,762
Total Stockholder Equity
Common Stock53,804
Retained Earnings -1,466,350
Other Stockholders Equity 2,029,733
Total Stockholder Equity (as reported)617,187
Total Stockholder Equity (calculated)617,187
+/-0
Other
Cash and Short Term Investments 188,828
Common Stock Shares Outstanding 517,390
Liabilities and Stockholders Equity 651,496
Net Debt 5,105
Short Long Term Debt Total 6,816



Balance Sheet

All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-30
> Total Assets 
761,289
693,303
594,308
701,760
651,496
651,496701,760594,308693,303761,289
   > Total Current Assets 
289,074
228,322
136,495
250,842
207,859
207,859250,842136,495228,322289,074
       Cash And Cash Equivalents 
3,893
7,185
7,912
4,675
1,711
1,7114,6757,9127,1853,893
       Short-term Investments 
172,409
142,492
89,357
69,282
187,117
187,11769,28289,357142,492172,409
       Inventory 
28,319
16,196
9,897
9,897
8,914
8,9149,8979,89716,19628,319
       Other Current Assets 
84,453
62,449
29,329
166,988
10,117
10,117166,98829,32962,44984,453
   > Long-term Assets 
472,215
464,981
457,813
450,918
443,637
443,637450,918457,813464,981472,215
       Property Plant Equipment 
20,136
18,593
17,108
15,895
14,296
14,29615,89517,10818,59320,136
       Intangible Assets 
451,777
446,087
440,404
434,722
429,040
429,040434,722440,404446,087451,777
> Total Liabilities 
178,617
141,234
44,595
43,750
34,309
34,30943,75044,595141,234178,617
   > Total Current Liabilities 
171,685
135,246
39,454
39,423
30,547
30,54739,42339,454135,246171,685
       Short-term Debt 
83,646
86,129
5,287
3,412
3,054
3,0543,4125,28786,12983,646
       Accounts payable 
8,016
6,186
13,590
4,540
8,065
8,0654,54013,5906,1868,016
       Other Current Liabilities 
80,023
42,931
20,577
31,471
19,428
19,42831,47120,57742,93180,023
   > Long-term Liabilities 
6,932
5,988
5,141
4,327
3,762
3,7624,3275,1415,9886,932
> Total Stockholder Equity
582,672
552,069
549,713
658,010
617,187
617,187658,010549,713552,069582,672
   Common Stock
44,837
44,837
44,837
49,674
53,804
53,80449,67444,83744,83744,837
   Retained Earnings -1,466,350-1,427,836-1,401,379-1,398,530-1,367,543
   Capital Surplus 00000
   Treasury Stock00000
   Other Stockholders Equity 
1,905,378
1,905,762
1,906,255
2,036,172
2,029,733
2,029,7332,036,1721,906,2551,905,7621,905,378



Balance Sheet

All numbers in thousands.




Cash Flow

All numbers in thousands.




Income Statement

All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue26,192
Cost of Revenue-44,122
Gross Profit-17,930-17,930
 
Operating Income (+$)
Gross Profit-17,930
Operating Expense-113,590
Operating Income-128,647-131,520
 
Operating Expense (+$)
Research Development-
Selling General Administrative79,438
Selling And Marketing Expenses-
Operating Expense113,59079,438
 
Net Interest Income (+$)
Interest Income-
Interest Expense-6,303
Net Interest Income--6,303
 
Pretax Income (+$)
Operating Income-128,647
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-132,722-124,572
EBIT - interestExpense = -132,722
-132,722
-126,419
Interest Expense6,303
Earnings Before Interest and Taxes (ebit)-126,419-126,419
Earnings Before Interest and Taxes (ebitda)-97,542
 
After tax Income (+$)
Income Before Tax-132,722
Tax Provision--
Net Income From Continuing Ops--132,722
Net Income-132,722
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses157,712
Total Other Income/Expenses Net-4,0750
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
VOLT.CC
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VOLT.CC.

VOLT.CC Daily Candlestick Chart
VOLLAR.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VOLLAR.CC.

VOLLAR.CC Daily Candlestick Chart
VIB.CC
6 hours ago

I found you a RSI Bullish Hidden Divergence on the daily chart of VIB.CC.

VIB.CC Daily Candlestick Chart
TRIO.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TRIO.CC.

TRIO.CC Daily Candlestick Chart
TKX.CC
6 hours ago

I found you a Golden Cross on the daily chart of TKX.CC.

TKX.CC Daily Candlestick Chart
TERC.CC
6 hours ago

I found you a Three Black Crows Candle Pattern on the daily chart of TERC.CC.

TERC.CC Daily Candlestick Chart
RENTBERRY.CC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of RENTBERRY.CC.

RENTBERRY.CC Daily Candlestick Chart
STOX.CC
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of STOX.CC.

STOX.CC Daily Candlestick Chart
STO.CC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of STO.CC.

STO.CC Daily Candlestick Chart
STM.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of STM.CC.

STM.CC Daily Candlestick Chart
SPORTS.CC
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SPORTS.CC.

SPORTS.CC Daily Candlestick Chart
SPIRIT.CC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SPIRIT.CC.

SPIRIT.CC Daily Candlestick Chart
SHIELD.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHIELD.CC.

SHIELD.CC Daily Candlestick Chart
SHB.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHB.CC.

SHB.CC Daily Candlestick Chart
SFM.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SFM.CC.

SFM.CC Daily Candlestick Chart
QI.CC
6 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of QI.CC.

QI.CC Daily Candlestick Chart
PYRO.CC
6 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PYRO.CC.

PYRO.CC Daily Candlestick Chart
PTF.CC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PTF.CC.

PTF.CC Daily Candlestick Chart
PREMIA.CC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PREMIA.CC.

PREMIA.CC Daily Candlestick Chart
POX.CC
6 hours ago

I found you a Death Cross on the daily chart of POX.CC.

POX.CC Daily Candlestick Chart
PLURA.CC
6 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of PLURA.CC.

PLURA.CC Daily Candlestick Chart
PLAY.CC
6 hours ago

I found you a MACD Bullish Hidden Divergence on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart
PHR.CC
6 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of PHR.CC.

PHR.CC Daily Candlestick Chart
PAYT.CC
6 hours ago

I found you a MACD Bearish Hidden Divergence on the daily chart of PAYT.CC.

PAYT.CC Daily Candlestick Chart